首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3622556篇
  免费   255813篇
  国内免费   9473篇
耳鼻咽喉   48923篇
儿科学   120036篇
妇产科学   99449篇
基础医学   508941篇
口腔科学   102249篇
临床医学   331906篇
内科学   706145篇
皮肤病学   85397篇
神经病学   293038篇
特种医学   137360篇
外国民族医学   941篇
外科学   540740篇
综合类   77900篇
现状与发展   8篇
一般理论   1397篇
预防医学   277611篇
眼科学   83913篇
药学   264332篇
  12篇
中国医学   7989篇
肿瘤学   199555篇
  2019年   28735篇
  2018年   40922篇
  2017年   31196篇
  2016年   35514篇
  2015年   40223篇
  2014年   55677篇
  2013年   83178篇
  2012年   112119篇
  2011年   118665篇
  2010年   71088篇
  2009年   67476篇
  2008年   110516篇
  2007年   117656篇
  2006年   119239篇
  2005年   114426篇
  2004年   110103篇
  2003年   105901篇
  2002年   102255篇
  2001年   175853篇
  2000年   180008篇
  1999年   151402篇
  1998年   43063篇
  1997年   37931篇
  1996年   38044篇
  1995年   36900篇
  1994年   33701篇
  1993年   31600篇
  1992年   117148篇
  1991年   113015篇
  1990年   109375篇
  1989年   105678篇
  1988年   96626篇
  1987年   94657篇
  1986年   88864篇
  1985年   84865篇
  1984年   63271篇
  1983年   53688篇
  1982年   31501篇
  1981年   28074篇
  1979年   55965篇
  1978年   39291篇
  1977年   33425篇
  1976年   31182篇
  1975年   32996篇
  1974年   39360篇
  1973年   37622篇
  1972年   35127篇
  1971年   32613篇
  1970年   30131篇
  1969年   28799篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
35.
36.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
37.
38.
Sinus venosus atrial septal defect (SV‐ASD) usually coexists with partial anomalous pulmonary vein connection (PAPVC). It is a difficult diagnosis in transthoracic echocardiography (TTE) due to eccentric position of defects. We present a rare case of atypical anatomical variation in PAPVC, which was never described before. Two right pulmonary veins drained into superior vena cava, which overrode SV‐ASD and interatrial septum, a third pulmonary vein into the right atrium. Complete diagnosis could not be set after TTE, nor transesophageal echocardiography, whereas angio‐CT was finally conclusive. This diagnostic approach allowed the surgical planning.  相似文献   
39.
40.
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号